FPAS
KURA icon

Focus Partners Advisor Solutions’s Kura Oncology KURA Stock Holding History

Focus Partners Advisor Solutions’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$145K Sell
13,173
-2,392
-15% -$22.6K ﹤0.01% 1193
2026
Q1 		$127K Sell
15,565
-7,324
-32% -$62.9K ﹤0.01% 1190
2025
Q4 		$238K Buy
22,889
+1,682
+8% +$17.6K ﹤0.01% 963
2025
Q3 		$210K Buy
+21,207
New +$151K ﹤0.01% 1058

Other funds holding KURA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $241M AUM 112.74% 1-Year Est. Return

Focus Partners Advisor Solutions's KURA Position: Q2 2026 in Review

Focus Partners Advisor Solutions reduced its Kura Oncology (KURA) stake by 15% in Q2 2026, selling an estimated $22.6K and leaving 13,173 shares worth $145K. The position accounts for ﹤0.01% of the portfolio, ranked #1193.

Focus Partners Advisor Solutions first reported a position in KURA in Q3 2025 and has held it in 4 quarters since. The position peaked at $238K in Q4 2025. 221 funds tracked by Wall St. Rank hold KURA as of Q2 2026.

  • Focus Partners Advisor Solutions held 13,173 shares of Kura Oncology worth $145K as of Q2 2026.
  • Focus Partners Advisor Solutions sold 2,392 Kura Oncology shares in Q2 2026, an estimated $22.6K.
  • Kura Oncology made up ﹤0.01% of Focus Partners Advisor Solutions's portfolio in Q2 2026, its #1193 holding.
  • Focus Partners Advisor Solutions first reported a position in Kura Oncology in Q3 2025 and has held it in 4 quarters since.
  • Focus Partners Advisor Solutions's Kura Oncology position peaked at $238K in Q4 2025.
  • 221 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2026.

Based on Focus Partners Advisor Solutions's 13F filing for Q2 2026, filed 6 Aug 2026.